Norbixin

Southern blot is a DNA hybridization assay used to detect a defined DNA sequence within restriction-digested or otherwise fragmented genomic DNA. The method separates DNA fragments by agarose gel electrophoresis, transfers the size-resolved DNA pattern onto a solid support, denatures the DNA to permit base pairing, and detects fragments that hybridize with a complementary labeled probe; the readout is a band, smear, or fragment-size distribution corresponding to the target sequence and its restriction-fragment context. The assay reflects sequence presence, restriction fragment length, gene copy pattern, structural rearrangement, insertion or deletion affecting restriction sites, and some repeat-length or terminal restriction fragment applications when the experimental design links the probe to those genomic features. Classic applications include Southern blot-based telomere terminal restriction fragment analysis and minisatellite-based DNA fingerprinting, which illustrate how the same

ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are

AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked

Plasmid construction refers to the method of producing recombinant plasmid by connecting the target DNA molecule fragment with the DNA molecule of a specific carrier in Escherichia coli.